VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 49 filers reported holding VOR BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $445,000 | -89.3% | 111,808 | -86.6% | 0.01% | -89.3% |
Q2 2022 | $4,142,000 | -17.7% | 833,333 | 0.0% | 0.08% | -8.5% |
Q1 2022 | $5,033,000 | -48.0% | 833,333 | 0.0% | 0.08% | -33.9% |
Q4 2021 | $9,683,000 | -25.9% | 833,333 | 0.0% | 0.12% | -13.9% |
Q3 2021 | $13,067,000 | -15.9% | 833,333 | 0.0% | 0.14% | -8.3% |
Q2 2021 | $15,542,000 | -56.7% | 833,333 | 0.0% | 0.16% | -53.3% |
Q1 2021 | $35,917,000 | – | 833,333 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,692,429 | $124,814,000 | 31.41% |
Trustees of Columbia University in the City of New York | 183,821 | $3,428,000 | 5.06% |
RA Capital Management | 11,120,973 | $207,406,000 | 3.33% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $20,042,000 | 2.05% |
Sarissa Capital Management LP | 707,010 | $13,186,000 | 1.05% |
SECTORAL ASSET MANAGEMENT INC | 405,324 | $7,559,000 | 0.61% |
Woodline Partners LP | 1,146,494 | $21,382,000 | 0.40% |
Artal Group S.A. | 550,000 | $10,258,000 | 0.21% |
NEXPOINT ASSET MANAGEMENT, L.P. | 50,000 | $933,000 | 0.20% |
Orbimed Advisors | 833,333 | $15,542,000 | 0.16% |